Thalassemia and sickle cell anaemia are common genetic disorders in India. Early testing, prenatal screening, and improved ...

Known as Zynteglo in Europe where it is approved to treat the rare blood disorder beta-thalassemia, the gene therapy has been given the all-clear by bluebird’s scientists after reviewing the ...

Norah Awad has lived with beta thalassemia major, a severe blood disorder that has required monthly transfusions since she ...

While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell transplantation (HSCT) remains the only widely accessible curative option for this ...

Thalassemia and Sickle Cell Anaemia are common genetic disorders, with options for treatment and prevention available.

India has around 50 million (5 crore) carriers of the ß (beta ... launched state-level thalassemia screening programs, targeting high-risk populations and offering genetic counseling.

Under this law, it was mandatory for couples to undergo thalassemia testing before marriage, while genetic counselling and diagnostic facilities for the disease were also to be introduced.

the first CRISPR/Cas9 gene-editing therapy in the UAE. This achievement opens new horizons and offers innovative treatment for patients suffering from sickle cell disease (SCD) and transfusion ...